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Abstract
Background: In the past, immune responses to several Brugia malayi immunodominant antigens have been
characterized in filaria-infected populations; however, little is known regarding Wolbachia proteins. We earlier
cloned and characterized few B. malayi (trehalose-6-phosphate phosphatase, Bm-TPP and heavy chain myosin,
BmAF-Myo) and Wolbachia (translation initiation factor-1, Wol Tl IF-1 and NAD+-dependent DNA ligase, wBm-LigA)
proteins and investigated the immune responses, which they triggered in animal models. The current study
emphasizes on immunological characteristics of these proteins in three major categories of filarial endemic zones:
endemic normal (EN, asymptomatic, amicrofilaraemic; putatively immune), microfilariae carriers (MF, asymptomatic
but microfilaraemic), and chronic filarial patients (CP, symptomatic and mostly amicrofilaraemic).
Methods: Immunoblotting and ELISA were carried out to measure IgG and isotype antibodies against these
recombinant proteins in various clinical categories. Involvement of serum antibodies in infective larvae killing was
assessed by antibody-dependent cellular adhesion and cytotoxicity assay. Cellular immune response was
investigated by in vitro proliferation of peripheral blood mononuclear cells (PBMCs) and reactive oxygen species
(ROS) generation in these cells after stimulation.
Results: Immune responses of EN and CP displayed almost similar level of IgG to Wol Tl IF-1 while other three
proteins had higher serum IgG in EN individuals only. Specific IgA, IgG1, IgG3 and IgM to Bm-TPP were high in EN
subjects, while BmAF-Myo additionally showed elevated IgG2. Enhanced IgA and IgG3 were detected in both EN
and CP individuals in response to Wol Tl IF-1 antigen, but IgG1 and IgM were high only in EN individuals. wBm-
LigA and BmAF-Myo exhibited almost similar pattern of antibody responses. PBMC isolated from EN subjects
exhibited higher proliferation and ROS generation when stimulated with all three proteins except for Wol Tl IF-1.
Conclusions: Overall, these findings display high immunogenicity of all four proteins in human subjects and
revealed that the EN population was exposed to both B. malayi and Wolbachia proteins simultaneously. In addition,
immune responses to Wol Tl IF-1 suggest possible role of this factor in Wolbachia-induced pathological responses
while immune responses to other three proteins suggest that these can be explored further as vaccine candidates.
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Background
Human lymphatic filariasis (LF) is a debilitating disease
caused by Wuchereria bancrofti, Brugia malayi and
Brugia timori and transmitted through mosquitoes.
Wuchereria bancrofti, the most prevalent species world-
wide, is responsible for about 80% of the infection in the
endemic areas, while B. malayi and B. timori are less
prevalent [1]. Approximately 120 million people are in-
fected and 1.39 billion are at the risk of infection in
tropical and subtropical areas across the globe, causing
serious socioeconomic consequences [2, 3]. Mass drug
administration of albendazole in conjunction with dieth-
ylcarbamazine or ivermectin is recommended for con-
trolling LF [4]. However, these strategies have limitations
associated with repeated administration of conventional
drugs due to limited adulticidal activity and reports of
development of drug resistance. Anti-wolbachial target-
ing with antibiotics against mutualistic endosymbiont
Wolbachia has been found effective [5–8]. However, be-
cause antibiotics require several weeks treatment for
macrofilaricidal activity, they are not suitable for mass
administration. Discovery of new macrofilaricidal drug
or a potent vaccine would be an appropriate comple-
mentary approach to control human bancroftian
filariasis.
Due to complex life-cycle of parasite, involving many
stages and varying host immune responses, human LF
presents wide clinical spectrum. In endemic zones, the
population can be grouped on the basis of clinical and
parasitological status into three major categories: en-
demic normal (EN, asymptomatic, amicrofilaraemic
completely free from any type of filarial infection; puta-
tively immune); microfilariae carriers (MF, asymptomatic
but microfilaraemic); and chronic filarial patients (CP,
symptomatic and mostly amicrofilaraemic). Immune sta-
tus of EN, MF and CP categories can highlight the sig-
nificance of filarial antigens in protective immunity,
diagnosis and/or pathogenesis. Endemic normal individ-
uals, despite of being continually exposed to infective
mosquito bites, remain immune to infection; this cat-
egory suggests that an antifilarial vaccine may be feasible
[9]. In recent years, rapid progress in filarial research has
provided new insights into host-parasite relationship and
associated immune responses, leading to the discovery
of antifilarial agents and potential vaccine molecules.
Many essential proteins of B. malayi and Wolbachia
have been characterized in search of potential vaccine
candidate and/or effective drug targets [10–16].
Heavy chain myosin of adult female B. malayi (BmAF-
Myo), an important body wall muscle protein, and
trehalose-6-phosphate phosphatase (TPP), a vital en-
zyme of trehalose biosynthetic pathway of filarial nema-
todes, serve many important physiological functions in
several helminth parasites [17–21]. Both have been
cloned and characterized by us [22, 23]. Brugia malayi TPP
(Bm-TPP) and BmAF-Myo both show cross-reactivity with
bancroftian human sera and provide significant protection
against infective larval challenge in experimental rodent
models [24–27]. Wolbachia translation initiation factor-1
(Wol Tl IF-1) is an excretory-secretory protein that also
elicits protective immunity in rodent model [28]. We have
also characterized and reported on NAD+-dependent DNA
ligase (wBm-LigA), another vital enzyme ofWolbachia with
an important role in DNA replication, transcription and
repair [29, 30].
The vital roles played by the above four proteins in fil-
arial biology and their strong reactivity with pooled hu-
man sera collected from subjects in a bancroftian
endemic area, especially those in the EN group, provided
a foundation for the current investigation, which ex-
plored the sero-reactivity and cellular immune response




Sub-periodic B. malayi was experimentally maintained
in rodent host Mastomys coucha (GRA ‘Giessen’
strain) through laboratory-bred mosquito vector Aedes
aegypti. The mosquitoes were fed on infected donor
animals. On day 9 ± 1, infective larvae (L3) of B.
malayi were recovered from fed mosquitoes by the
Baermann method [15].
Study population
Blood samples were collected at Tiruvallur district and
its surrounding villages, Chennai, India. All bancroftian
sera samples were collected in the same manner and
time frame in March 2015. Sampling was carried out
with the help of paramedical staff provided by the Pri-
mary Health Center (PHC) and collected blood samples
were divided into EN, MF and CP categories. The indi-
viduals were categorized as EN, MF and CP groups
based on record available at these centers as well as,
physical examination, presence of microfilariae (mf) and
circulating filaria antigen (CFA). Individuals who were
symptom-free, negative for CFA in ICT card test and mf
in thick night blood smears were grouped as EN. The in-
habitants found positive in ICT and had mf in night
blood smears were grouped under MF category while
those displaying symptoms of clinical filarial disease
such as, lymphedema, lymphadenitis, lymphangitis or
elephantiasis were designated as CP category. Details of
all individuals participating in the current study were
listed in Additional file 1: Table S1. NEN sera samples of
non-endemic zone of India (Jammu & Kashmir) col-
lected and stored earlier at -80 °C were used.
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Overexpression and purification of B. malayi recombinant
proteins
Genes encoding Bm-TPP and BmAF-Myo were cloned
and proteins were expressed and purified as described
earlier [22, 23]. In brief, Bm-TPP coding sequence
(GenBank: XM_001893174) and BmAF-Myo coding se-
quence (GenBank: AY705730) were PCR amplified from
cDNA of adult worms, cloned into topo T/A (3.9 bp)
vector and subcloned in expression vector pET28a (+)
and pET28b, respectively. After transformation of the re-
combinant constructs in competent Escherichia coli
(DE3) BL21 (Novagen, Madison, WI), logarithmic phase
culture was induced with 0.5 mM isopropyl β-D thioga-
lactoside (IPTG; Thermo Scientific, Waltham, Massa-
chusetts, United States) for 5 h at 37 °C (Bm-TPP) and
30 °C (BmAF-Myo) at 220 rpm for protein overexpres-
sion. The cells were harvested, and the pellet resus-
pended in 50 mM sodium phosphate buffer (pH 8.0)
containing 300 mM NaCl, 2 mM phenylmethylsulfonyl
fluoride (PMSF) and 10 mM imidazole. The cells were
disrupted in a sonicator and centrifuged, and proteins
were purified by nickel nitrilotriacetic acid (Ni-NTA;
Qiagen, Hilden, Germany) agarose affinity column. The
purified proteins were dialyzed overnight against 50
mM NaH2PO4 at 4 °C and protein concentration was
determined by Bradford method [31]. Single band of
proteins were obtained on 10% sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE), con-
firmed the purity of protein in eluted fraction. Both the
recombinant proteins had < 1 EU/mg LPS contamin-
ation as determined by toxin sensor limulus amebocyte
lysate (LAL) assay kit (Thermo Fisher Scientific, Waltham,
Massachusetts, United States) which was removed by
polymyxin B agarose resins column (Sigma-Aldrich, St.
Louis, Missouri, USA).
Overexpression and purification of Wolbachia
recombinant proteins
We earlier reported on the cloning of genes encoding
Wol Tl IF-1 and wBm-LigA of B. malayi endosymbiont
Wolbachia and expression and purification of recombin-
ant proteins [28, 29]. Briefly, wol infA (NCBI 3266784)
and wBm-ligA genes (2,052 bp) encoding Wol Tl IF-1
and wBm-LigA were PCR-amplified, cloned into
pTZ57R/T (2.88 kb) vector, subcloned into pET28a(+)
vector (Novagen, Madison, WI) and transformed into
Rosetta cells. Recombinant proteins were over-expressed
by 0.5 mM IPTG for 6 h at 25 °C. The cell pellet was
suspended in Buffer A (20 mM Tris-Cl pH 8.0, 250 mM
NaCl, 10 mM imidazole) in presence of lysozyme (1 mg/
ml) and Triton X-100 (0.1%) for cell lysis for wBm-LigA.
The cell pellet for Wol Tl IF-1 protein was suspended in
50 mM NaH2PO4 buffer (pH 8.0) containing 250 mM
NaCl, 1 mM PMSF and 10 mM imidazole. These
proteins were purified by Ni-NTA column and analyzed
on 10% SDS-PAGE as single band. The protein content
estimation, endotoxin level determination and removal
were done as described above.
Screening of serum antibodies to Bm-TPP, BmAF-Myo,
Wol Tl IF-1 and wBm-LigA by immunoblotting
Sero-reactivity of human bancroftian subjects with all the
four recombinant proteins was observed in Western blot
using sera of different categories (EN, n = 24; MF, n = 21;
CP, n = 24; NEN, n = 10) as primary antibody. Purified re-
combinant proteins along with prestained molecular
weight protein marker (Puregene, Genetix, New Delhi,
India) were run on 10% or 15% (Wol Tl IF-1) SDS-PAGE
and transferred to polyvinylidene fluoride (PVDF) mem-
brane (TE 77 PWR Semi-dry transfer unit, Amersham
Biosciences, Little Chalfont, United Kingdom). Membrane
was cut into strips, blocked in 3% skim milk for 2 h at
room temperature, washed thrice with PBS containing
0.5% Tween 20 (PBST), and individually incubated at 25 °C
with individual patient serum sample of different categories
at 1:800 dilution. Strips were re-washed with PBST and re-
incubated with anti-human IgG horseradish peroxidase
conjugate (Sigma-Aldrich, St. Louis, Missouri, USA) at
1:10,000 dilution for 2 h at 25 °C. The strips were later de-
veloped with 3,3′-diaminobenzidine tetra hydrochloride
(DAB) in presence of H2O2 (Sigma-Aldrich, St. Louis,
Missouri, USA).
Enzyme-linked immunosorbent assay (ELISA)
Serum antibody levels to each protein in each group of
patients were determined by indirect ELISA as described
previously [25]. In brief, ELISA plates (Nunc, Roskilde,
Denmark) were coated with 1 μg/ml each of Bm-TPP,
BmAF-Myo, Wol Tl IF-1 and wBm-LigA (100 μl/well) in
carbonate buffer (pH 9.6) separately and incubated over-
night at 4 °C. After three washings with PBST, plates
were blocked with 200 μl/well of 3.5% skim milk for 2 h
at 37 °C. Pooled human sera of each category were used
as primary antibodies and antibody titers were obtained
by 2-fold serial dilutions (1:50 to 1:25,600) in triplicate.
Primary antibody (100 μl/well) was added and plates
were incubated at 37 °C for 2 h, followed by washing
and re-incubation at 37 °C for 1 h in presence of anti-
human IgG-HRP (1:10,000). The reaction was developed
by orthophenylenediamine (OPD) and terminated by
adding 2.5 N H2SO4. The absorbance was read at 492
nm in ELISA multi-plate reader (Tecan, Schweiz, AG,
Switzerland). All individual sera (EN, n = 20; MF, n = 20;
CP, n = 20 and NEN, n = 10) were subsequently tested in
ELISA at 1:800 dilution and IgG antibody level was de-
termined in individual serum samples of each category
after coating the plates with each recombinant protein.
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Measurement of antibody isotypes
Different isotypes were also measured in the sera of each
patient of all categories. Briefly, ELISA plates were
coated with 0.1 μg/ml of each protein for overnight at 4
°C, blocked, washed and re-incubated with primary anti-
body (human sera of different groups) at 1:800 dilution.
After washing, ELISA plates were re-incubated with
HRP conjugated anti-human IgA, IgM, IgE, IgG1, IgG2,
IgG3 and IgG4 monoclonal antibodies (Abcam, Cambridge,
UK) as secondary antibodies (1:5,000). Color was developed
as above and absorbance was recorded at 492 nm using an
ELISA reader.
Isolation of human peripheral blood mononuclear cells
(PBMCs)
Heparinized venous blood of EN, MF and CP (5 patients/
category) were collected and diluted 1:1 with PBS.
PBMCs were isolated by layering diluted blood on
Histopaque 10771 (Sigma-Aldrich, St. Louis, Missouri,
USA) and tubes were centrifuged at 400× g for 30
min. Cells were collected from the interface of histo-
paque and plasma, washed twice with Roswell Park
Memorial Institute medium 1640 (RPMI 1640) con-
taining 1% antibiotic-antimycotic solution (Cell clone,
Genetix, New Delhi, India), re-centrifuged and finally
suspended in complete RPMI (C-RPMI 1640), fortified
with 1% antibiotic-antimycotic solution and 10% FBS
(Sigma-Aldrich, St. Louis, Missouri, USA) [32]. Try-
pan blue dye exclusion method was used to check the
viability of cells.
Depletion of bancroftian serum antibodies to Bm-TPP,
BmAF-Myo, Wol Tl IF-1 and wBm-LigA
Anti-Bm-TPP, anti-BmAF-Myo, anti-Wol Tl IF-1 and
anti-wBm-LigA antibodies present in the pooled sera of
EN, MF and CP individuals (detected in blot and ELISA)
were depleted by repeated binding of sera with Bm-TPP,
BmAF-Myo, Wol Tl IF-1 and wBm-LigA coupled Ni-
NTA agarose resins as described previously [26]. In
brief, 1 mg of his-tagged recombinant proteins were
coupled to Ni-NTA resins individually at 4 °C overnight.
Resins were washed with PBS to remove unbound
proteins and incubated with 200 μl of pooled sera at 4 °C.
After centrifugation, supernatant was collected. This anti-
body binding was repeated until supernatant did not react
with recombinant protein in ELISA. The antibody-
depleted sera were later used in antibody-dependent cell-
mediated cytotoxicity (ADCC) assay.
Antibody-dependent cell-mediated cytotoxicity (ADCC)
assay
In vitro ADCC assay was performed as described previ-
ously [14, 33, 34]. Briefly, in a 96-well culture plate
(Becton Dickinson, Franklin Lakes, New Jersey,USA),
approximately 10–20 L3 of B. malayi were cultured in
triplicates with 0.2 × 106 PBMCs (collected from a nor-
mal healthy human volunteer) and 50 μl each of pooled
EN, MF, CP and NEN sera or protein-depleted EN, MF
and CP sera. Sera of each group were pooled by taking
equal quantity from all 20 individuals of the group. Each
well contained 200 μl RPMI 1640 media and plate was
incubated for 48 h at 37 °C in presence of 5% CO2. The
experiment was repeated thrice. The larval viability was
determined microscopically; viable larvae moved actively
while dead larvae were flaccid, damaged and had clumps
of cells attached to them. Using the formula [(Number
of dead larvae/Total number of larvae) × 100] the %
killing of larvae was calculated.
In vitro proliferation of PBMCs in presence of
recombinant proteins and mitogens
PBMCs of EN, MF and CP subjects were cultured in 96-
well round-bottomed microtiter plates (0.2 × 105 cells/
well in C-RPMI 1640). Cells used as positive controls
were stimulated at 37 °C with Concanavaline A (ConA,
5 μg/ml). Experimental wells contained 10 μg/ml of Bm-
TPP or BmAF-Myo or 20 μg/ml of Wol T1 IF-1 or
wBm-LigA. Wells containing medium with cells only,
served as negative controls. Optimum concentration of
recombinant proteins and mitogens were previously de-
termined by exposing PBMCs of a normal healthy vol-
unteer to various concentrations (1 to 20 μg/ml) of each
recombinant protein. Cells were incubated for 72 h in
case of proteins, while ConA was done for only 48 h. All
cultures were done in triplicate, and cell proliferation
was determined by MTT assay using the formula: stimu-
lation index (SI) = absorbance of recombinant stimulated
cells/absorbance of unstimulated cells. The stimulation
indices indicate the cellular immune response of human
population to the recombinant protein.
Reactive oxygen species (ROS) detection
PBMCs (0.2 × 105 cells/well) were cultured in triplicates
for 48 h with recombinant proteins at the same concen-
tration as for PBMC proliferation in CO2 incubator at
37 °C. After incubation, PBMCs were scrapped and
washed twice with PBS. Finally, dichloro-dihydro-
fluorescein diacetate DCFH-DA (10 μM) dye was added
to the cells, which were then incubated at 37 °C for 30
min in dark. Cells were washed, suspended in PBS, and
kept on ice for an immediate detection by flow cytome-
try. Data were acquired by FACS Conto II (Becton
Dickinson, San Jose, CA) and analyzed using the FlowJo
software [35].
Statistical analysis
Data were summarized as means ± SD (standard devi-
ation). Data were subjected to non-parametric analysis
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after ascertaining normality by Shapiro-Wilk’s test and
homogeneity of variances between the groups by
Levene’s test. Groups were compared by Kruskal-Wallis
ANOVA and the significance of the differences in mean
ranks between groups was assessed by Mann-Whitney
U-test (adjusted Z-value and P-value). A two-tailed P <
0.05 was considered statistically significant. Analysis
were performed on STATISTICA software (Windows
version 7.1, Stat Soft, Inc., USA). Test statistics with
exact P-values are presented in Additional file 2: Tables
S2-S14.
Results
All four proteins were successfully overexpressed and
purified by affinity chromatography
All four recombinant proteins were overexpressed and
purified by Ni-NTA column. Bm-TPP, BmAF-Myo, Wol
Tl IF-1 and wBm-LigA were eluted in phosphate/Tris
(wBm-LigA) buffer using 250 mM imidazole concentra-
tion. Single bands were obtained on 10% SDS PAGE
confirming the presence of purified recombinant pro-
teins in eluted fraction. Molecular masses of Bm-TPP,
BmAF-Myo, Wol Tl IF-1 and wBm-LigA were ~60kDa,
~73kDa, ~13kDa and ~75kDa, respectively (Additional
file 3: Figure S1).
Reactivity of W. bancrofti serum antibodies with B. malayi
and Wolbachia recombinant proteins
Seventy nine human serum samples including NEN (10),
EN (24), MF (21) and CP (24) were tested individually
for antibody reactivity with all the four recombinant pro-
teins in Western blotting using anti-human IgG-HRP as
secondary antibody. None of the ten NEN sera demon-
strated any IgG antibody reactivity with Bm-TPP or
BmAF-Myo, and only one reacted with Wol Tl IF-1 and
wBm-LigA. Twenty-three of the 24 EN sera reacted
positively with all the four proteins. In the 21 MF sam-
ples, 20 were positive for anti-Bm-TPP and anti-BmAF-
Myo antibodies, while all 21 samples showed reactivity
with Wol Tl IF-1 and wBm-LigA in blots. All of the 24
CP sera were positive for anti-Wol Tl IF-1 and anti-
wBm-LigA antibodies, but BmAF-Myo reacted with only
23 of these and Bm-TPP with only 22. Among the
clinical groups, MF category consistently exhibited low
IgG reactivity resulting into low band intensity. IgG anti-
body reactivity to Wol Tl IF-1 was also not as intense as
with the other three proteins including wBm-LigA.
Thus, overall comparison of the antibody reactivity to
both B. malayi and Wolbachia proteins revealed that
human subjects staying in W. bancrofti endemic area are
exposed to Bm-TPP, BmAF-Myo, Wol Tl IF-1 and wBm-
LigA proteins and generated substantial IgG antibodies
to these antigens. The reactivity was specific; non-
specific reaction was observed in only one NEN individ-
ual who showed reactivity with both the Wolbachia
recombinant proteins (Fig. 1a-d; Table 1).
Endemic normal population have high IgG antibody titer
to the four proteins studied
IgG reactivity was assessed by measuring the antibody
titer in pooled human sera of each category including
NEN control. Using 2-fold serial dilution of pooled sera,
8-fold higher IgG antibody titers were detected against
BmAF-Myo or Bm-TPP in EN (1/6,400) as compared to
Fig. 1 Immunoblotting of recombinant proteins with serum samples of various bancroftian categories. All serum samples of NEN (n = 10), EN
(n = 24), MF (n = 21) and CP (n = 24) categories were checked for the presence of a anti-Bm-TPP antibodies; b antibodies against recombinant
BmAF-Myo; c anti-Wol Tl IF-1 antibodies; and d antibodies against recombinant wBm-LigA. Each strip represents immunoreactivity of individual
serum sample with recombinant B. malayi and Wolbachia proteins. First strip in each group represents a standard molecular weight marker
(PG-PMT2922, Puregene Genetix)
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CP or MF (1/800). On the other hand, IgG levels were
lower but similar against both the Wolbachia recom-
binant proteins (1/800) in all the three categories.
Thus, it was apparent that EN population produced
higher specific-IgG levels to B. malayi proteins than
other clinical categories while all the clinical categor-
ies of patients contained IgG antibodies to Wolbachia
proteins though the titer was comparatively low
(Additional file 4: Figure S2).
Further, all serum samples were individually tested in
indirect ELISA at 1/800 dilution after coating the plate
with four recombinant proteins to observe the differen-
tial specific IgG response. IgG antibody level for Bm-
TPP was significantly higher in EN individuals than in
the CP and MF group. Likewise, with the BmAF-Myo
and wBm-LigA, the EN category again showed high OD
values, while no significant difference was observed in
MF and CP categories. In general, antibody responses
were lowest in MF group, although even in this group
the values were significantly higher than NEN group.
Wol Tl IF-1 had the same level of IgG reactivity in EN
and CP group, a level significantly higher than MF
group. The combined graph clearly shows that in EN
category, B. malayi recombinant proteins (Bm-TPP and
BmAF-Myo) exhibited higher serum reactivity than
Wolbachia proteins (Wol Tl IF-1 and wBm-LigA). IgG
level observed in this population was highest for BmAF-
Myo (Fig. 2a-e).
Isotype antibody response
Humoral immune response was further investigated
by analyzing the antibody isotypes in sera of the same
groups (EN, MF, CP and NEN control) reacting with
B. malayi and Wolbachia recombinant proteins. IgA,
IgG1, IgG3 and IgM isotypes were predominantly and
significantly higher in EN subjects than other categor-
ies for Bm-TPP while no significant differences were
observed for IgG4, IgG2 and IgE. BmAF-Myo more
strongly reacted with the antibodies present in the
EN sera showing high IgA, IgG1, IgG2, IgG3 and
IgM, but no significant differences were observed in
IgG4 and IgE levels among the four categories. Re-
garding Wol Tl IF-1-specific antibody isotype levels,
reactivity was higher for IgA and IgG3 in EN and CP
category as compared to MF and NEN individuals.
IgG1 and IgM were high in EN category while no
group showed significant changes in IgG4 and IgE
levels. wBm-LigA showed similar isotype reactivity as
in BmAF-Myo, although the antibody levels were
lower. Overall isotype investigation revealed that IgA
and IgM isotypes were higher in EN category irre-
spective of recombinant protein used in ELISA
(Fig. 3a-d).
Antibodies to recombinant proteins in bancroftian sera
contribute to L3 killing via ADCC
Individuals residing in endemic area of bancroftian filar-
iasis continuously get exposed to L3, triggering forma-
tion of antibodies. These antibodies participate in larvae
killing via ADCC mechanism, and have a role in provid-
ing immunity to EN individuals. In vitro ADCC assay
was carried out to observe cellular adherence, cytotox-
icity and larval killing in the presence of patients’ sera
containing antibodies to four recombinant proteins.
These findings revealed that antibodies present in pooled
EN sera participated more actively in cellular adherence
and caused parasite death within 48 h, as compared to
antibodies present in MF and CP pooled sera. The differ-
ential role of protein-specific antibodies was investigated
by their depletion and incubating the L3 with antibody-
depleted EN/MF/CP pooled sera. Cellular adherence and
subsequent cytotoxic killing of larvae was reduced pro-
foundly after depletion of anti-Bm-TPP and anti-wBm-
LigA antibodies especially in EN individuals. The other
proteins also exhibited reduced ADCC, but to a lesser
degree which was also not significant (Fig. 4a-s; Table 2).
Brugia malayi and Wolbachia recombinant proteins
promote PBMC proliferation in vitro
PBMCs upon stimulation with an immunogen or mito-
gen undergo clonal proliferation of B-cells, T-cells and
initiation of humoral and cellular immune response by
monocytes connecting both arms of immunity. This
cell-proliferation is considered as an indirect marker for
predicting the immunogenic response of host to a par-
ticular antigen. The EN population responded more
strongly to all the recombinant proteins than did MF
and CP individuals, except Wol Tl IF-1 where
Table 1 Immunoblotting of recombinant proteins with clinical sera samples
Clinical category Bm-TPP BmAF-Myo Wol Tl IF-1 wBm-LigA
No. of positive samples/
Total no. of samples
No. of positive samples/
Total no. of samples
No. of positive samples/
Total no. of samples
No. of positive samples/
Total no. of samples
NEN 0/10 0/10 1/10 1/10
EN 23/24 23/24 23/24 23/24
MF 20/21 20/21 21/21 21/21
CP 22/24 23/24 24/24 24/24
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stimulation was almost same in EN and CP categories.
Brugia malayi proteins caused higher cell and similar
proliferation (BmAF-Myo SI 5.99; Bm-TPP SI 5.79),
which was statistically significant as compared to MF or
CP groups. wBm-LigA demonstrated similar effects with
mean SI 4.31 ± 1.90 for EN group that was significantly
higher than in the MF or CP categories. Wol Tl IF-1 also
led to cell proliferation in PBMCs of EN subjects (mean
SI 3.87) which was significantly higher than in the MF
population but not in the CP group. Strong proliferation
of cells isolated from EN subjects in response to Bm-
TPP, BmAF-Myo and wBm-LigA suggests the possible
involvement of these proteins in protection mechanism
that keeps EN population free from filarial infection.
However, similar SI index of Wol Tl IF-1 in EN and CP
categories may suggest involvement of this factor in pro-
tection and/or pathogenesis (Fig. 5a-d).
Higher stimulation of ROS generation in EN subjects as
compared to MF and CP category
Our earlier findings on immunization of rodents
with Bm-TPP and Wol Tl IF-1 have shown produc-
tion of ROS by macrophages rich peritoneal cells
[25, 28]. Here we analyzed oxidative burst in PBMCs
of all clinical categories after stimulation with the
recombinant proteins. Results demonstrate clear-cut
shifting of average fluorescence intensity in EN
group unlike MF or CP group and this was more
Fig. 2 IgG antibody levels in bancroftian sera against recombinant B. malayi and Wolbachia proteins. IgG antibodies in each individual of different
categories were measured by ELISA for a Bm-TPP; b BmAF-Myo; c Wol Tl IF-1; and d wBm-LigA proteins and presented in scatter plots where
each dot represents absorbance of individual sera and horizontal lines represent the mean. e Bar graphs showing protein levels (mean + standard
deviation) in each group. Groups were compared using Kruskal-Wallis ANOVA and the significance of the differences in mean ranks
between groups was assessed by Mann-Whitney U test. Data are from one of the three similar experiments using same serum sample.
*P < 0.05; **P < 0.01; ***P < 0.001
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prominent on stimulation with B. malayi recombin-
ant proteins. Wol Tl IF-1, on the other hand, stimu-
lated cells from both EN and CP categories to
almost similar extent. Mean florescence of stimulated
PBMCs for ROS for all three proteins was also
significantly higher in EN individuals as compare to
other categories. In Wol Tl IF-1-stimulated cells,
nearly the same average geometric mean fluores-
cence was observed for EN and CP categories
(Fig. 6a-g).
Fig. 3 Antibody isotypes in sera of Wuchereria bancrofti-exposed humans to recombinant proteins. IgA, IgG1, IgG2, IgG3, IgG4, IgE and IgM
isotype antibodies in various groups (EN, MF, CP and NEN) for a Bm-TPP; b BmAF-Myo; c Wol Tl IF-1; and d wBm-LigA proteins, measured by
ELISA after coating the plate with 0.1 μg/ml of each protein antigen. Data (OD values corresponding to antibody isotype reactivity of serum of all
individuals of a group for each protein) are summarized as mean + standard deviation (NEN, n = 10; EN, MF and CP, n = 20). For each protein,
comparison between groups was performed by Kruskal-Wallis ANOVA and the significance of the differences in mean ranks between groups was
assessed by Mann-Whitney U test. Data are from one of the three similar experiments using same serum sample. *P < 0.05; **P < 0.01; ***P < 0.001
Fig. 4 L3 larvae of B. malayi recovered from cultures after antibody dependent cellular cytotoxicity assay. L3 were incubated with PBMCs and a
without EN sera (negative control); b with NEN pooled sera; c-e with pooled EN sera; f with pooled EN sera after depleting anti Bm-TPP anti-
bodies; g with anti-BmAF-Myo antibodies depleted EN pooled sera; h with anti-Wol Tl IF-1 antibodies depleted EN pooled sera; i with anti-wBm-
LigA antibodies depleted EN sera; j with pooled MF sera; k with pooled MF sera after depleting anti Bm-TPP antibodies; l with anti-BmAF-Myo
antibodies depleted MF pooled sera; m with anti-Wol Tl IF-1 antibodies depleted MF pooled sera; n with anti-wBm-LigA antibodies depleted MF
sera; o with pooled CP sera; p with pooled CP sera after depleting anti-Bm-TPP antibodies; q with anti-BmAF-Myo antibodies depleted CP pooled
sera; r with anti-Wol Tl IF-1 antibodies depleted CP pooled sera; and s with anti-wBm-LigA antibodies depleted CP sera. Photographs were
captured on a phase contrast microscope (Nikon, Japan). Scale-bars: 0.05 mm in all panels
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Discussion
Bm-TPP and BmAF-Myo earlier showed good immunopro-
phylactic efficacy in experimental animal models in our la-
boratory [24–27]. We also cloned and characterized two
Wolbachia proteins, Wol Tl IF-1 and wBm-LigA [28–30].
In the current investigation, we undertook immune
characterization of all the four recombinant proteins to as-
sess both humoral and cellular immune response of human
subjects staying in W. bancrofti-endemic areas. The IgG
antibody response was evaluated both qualitatively and
quantitatively in all categories of sera to understand
humoral immune response of human host to above recom-
binant antigens. Bm-TPP and BmAF-Myo revealed specific
reaction with bancroftian antibodies as all serum samples
of filaria-free zone (NEN category) failed to show any
reaction indicating that these proteins are well accessed by
the human host. As EN population get continuously
exposed to L3 and immune to infection, strong immuno-
logical responses of EN individuals to these proteins sug-
gested that the proteins are likely to be derived primarily
from infective larval stages. Nevertheless, adult and micro-
filariae do share these proteins as observed earlier [23, 24].
Reactivity of bancroftian IgG with recombinant Wol Tl IF-
1 and wBm-LigA was also filaria-specific; however, one of
the ten sera in NEN category showed some reactivity in
both blot and ELISA. The possible reason could be a cross-
reaction with some bacteria or some other organism carry-
ing an epitopic region similar to these wolbachial proteins.
Death and disintegration of filarial worms has been sug-
gested to expose host to proteins of Wolbachia that may
anticipate higher reactivity of CP individuals to Wolbachia
proteins; however, almost similar band intensity or ELISA
antibody titer observed in EN sera suggests the presence of
anti-wolbachial antibodies in EN population as well. As
these subjects are continuously exposed to infective larval
invasion and larvae do not normally develop further and
die thus may release Wolbachia intermittently. Strong re-
activity of all the four recombinant proteins with EN sera
points towards the immunoprotective nature of these pro-
teins. IgG titers to B. malayi antigens were higher than
those of Wolbachia antigens also suggests that B. malayi
antigens could be a better candidate for vaccine as compare
to Wolbachia antigens. Earlier, few recombinant B. malayi/
W. bancrofti proteins have been proposed as vaccine candi-
dates based on their strong IgG reactivity with EN individ-
uals [33, 36, 37]. Apart from IgG antibody, protein specific
serum IgA and IgM were also in higher concentration in
EN group while all MF individuals contained low antibody
reactivity and CP had moderate. A protective role for IgA
has been reported for several helminthic infections such as
Schistosoma mansoni, Taenia taeniformis, Trichinella spira-
lis, including cattle filarial parasite Setaria digitata [38–41].
Protective role of IgM has also been postulated in
Strongyloides stercoralis, Brugia phangi and W. ban-
crofti infections [37, 42, 43].
Previous studies in our laboratory in rodent models il-
lustrated that Bm-TPP and Wol Tl IF-1 generated a
mixed Th1/Th2 and Th2 biased immune responses re-
spectively [26, 28]. However, in the current study human
EN population showed a Th2 biased immune response
for Bm-TPP and Wol Tl IF-1 with predominant increase
in IgG1 and IgG3 isotype. IgG1, IgG2 and IgG3 isotype
levels were found to be higher in EN population against
BmAF-Myo and wBm-LigA recombinant proteins. In
several studies involving various recombinant filarial
proteins, elevated levels of IgG1, IgG2 and IgG3 isotypes
have been reported in putatively immune individuals
[14, 33, 36, 44, 45] suggesting their role in filarial larval
killing. Nevertheless, polarization of T-helper cell
Table 2 Results of ADCC assay against B. malayi L3 using
human sera
No. Groups % Killing
(mean ± SD)
1 Control (L3 + PBMCs) 0
2 NEN (L3 + PBMCs + Pooled NEN sera) 9.7 ± 4.0
3 EN (L3 + PBMCs + Pooled EN sera) 84.1 ± 3.6a
4 L3 + PBMCs + anti Bm-TPP antibodies
depleted Pooled EN sera
30.2 ± 3.0b
5 L3 + PBMCs + anti BmAF-Myo antibodies
depleted Pooled EN sera
51.1 ± 1.9
6 L3 + PBMCs + anti Wol Tl IF-1 antibodies
depleted Pooled EN sera
47.6 ± 4.1
7 L3 + PBMCs + anti wBm-LigA antibodies
depleted Pooled EN sera
29.4 ± 4.2b
8 MF (L3 + PBMCs + Pooled MF sera) 31.5 ± 1.6
9 L3 + PBMCs + anti Bm-TPP antibodies
depleted Pooled MF sera
21.8 ± 1.6
10 L3 + PBMCs + anti BmAF-Myo antibodies
depleted Pooled MF sera
22.9 ± 4.9
11 L3 + PBMCs + anti Wol Tl IF-1 antibodies
depleted Pooled MF sera
23.9 ± 3.4
12 L3 + PBMCs + anti wBm-LigA antibodies
depleted Pooled MF sera
22.7 ± 3.5
13 CP (L3 + PBMCs + Pooled CP sera) 35.0 ± 3.6
14 L3 + PBMCs + anti Bm-TPP antibodies
depleted Pooled CP sera
23.4 ± 1.4
15 L3 + PBMCs + anti BmAF-Myo antibodies
depleted Pooled CP sera
27.8 ± 2.9
16 L3 + PBMCs + anti Wol Tl IF-1 antibodies
depleted Pooled CP sera
22.1 ± 2.6b
17 L3 + PBMCs + anti wBm-LigA antibodies
depleted Pooled CP sera
24.9 ± 1.8
Data are summarized as Mean ± SD, n = 3. The comparison were done
between pooled EN/MF/CP sera and pooled EN/MF/CP sera after depletion of
anti Bm-TPP/anti BmAF-Myo/Wol Tl IF-1/anti wBm-LigA antibodies
aP < 0.05; significant differences between pooled EN sera with pooled MF sera
and pooled CP sera
bP < 0.05; significant differences of % killing in each group after depletions of
protein-specific antibodies with respect to undepleted pooled sera
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response in EN category towards type 1 or type 2 cannot
be specifically be mentioned since it depends upon the
type of protein antigen [36, 45]. IgG4 is a marker of ac-
tive filarial infection [46, 47] and not much variation in
the level of this antibody subclass in any clinical category
of human subjects was noticed for individual proteins.
In CP individuals, IgG3 antibodies against Wol Tl IF-1
were found to be significantly higher than in MF group
(though lower than EN) indicating exposure of CP and
EN both population to Wol Tl IF-1 protein. The role of
this factor in the development of pathology/protection
in filarial infection needs to be resolved before this pro-
tein is considered further for vaccination experimenta-
tions. IgG isotyping data also suggest prospective
immunogenicity of Bm-TPP and BmAF-Myo; however,
more studies are required to explore the functions of
Wolbachia proteins.
IgG1 and IgG3 are cytophilic antibodies that bind to
FcγRI and RII receptors expressed on macrophages, neu-
trophils, eosinophils and mediate parasite killing via
ADCC mechanism [48]. Amongst all three categories,
EN serum pool brought about highest cytotoxicity and
parasite mortality with respect to MF and CP serum
pool. In vitro killing of B. malayi L3 in presence of EN
sera is likely to be mediated by these two IgG subclasses
that were abundant in EN patients and promoted cellu-
lar adherence and cytotoxicity. This ability was lost once
the EN sera were adsorbed with proteins in which Bm-
TPP and wBm-LigA, substantiating their role in larval
killing and correlated with their profound immunopro-
phylactic efficacy [26]. Enhanced proliferative response
of Bm-TPP, BmAF-Myo and wBm-LigA suggested the
role of these proteins in inducing cellular immune re-
sponse; however, Wol Tl IF-1 needs careful investigation
as vaccine candidate owing to its strong reactivity with
CP antibodies and inducing cell proliferation in CP pa-
tients. All four recombinant antigens show T-cell hypo-
responsiveness in MF group as the SI values were found
to be consistently low. The proteins demonstrated both
antigen-specific and non-specific hyporesponsiveness
similar to other immunogens like Con A. Few other fil-
arial antigens have also been reported to respond in the
same manner with EN patients [34, 44]. Brugia malayi
proteins stimulated PBMCs generate ROS in EN popula-
tion though proteins from Wolbachia did not participate
to that extent. However, Wol Tl IF-1 induces ROS in
both EN and CP categories. These findings thus further
substantiate a protective role of all the four recombinant
proteins; nevertheless, Wol Tl IF-1 may also induce im-
munopathological responses that need to be explored
further. We earlier mentioned that in vitro killing of
both L3 and microfilariae is mediated via IFN-γ acti-
vated macrophages through ROS generation on
immunization of animals with Bm-TPP and Wol Tl IF-1
these previous findings support current observations
[25, 28].
The correlation between responses of serum category
with the type of recombinant protein was also revealed
Fig. 5 PBMC proliferation of human subjects. a PBMCs of EN, MF and CP stimulated with CoA (5 μg/ml) or Bm-TPP (10 μg/ml); b PBMCs
stimulated with CoA (5 μg/ml) or BmAF-Myo (10μg/ml); c CoA (5 μg/ml) or Wol Tl IF-1 (20 μg/ml) stimulated PBMCs; d EN, MF and CP
clinical samples’ PBMC stimulated with CoA (5 μg/ml) or wBm-LigA (10 μg/ml). Proliferation was assessed as stimulation index (SI) by MTT
assay. Data are from one of the three similar experiments and summarized as mean + standard deviation (n = 5). Groups were compared
using Kruskal-Wallis ANOVA and the significance of the differences in mean ranks between groups was assessed by Mann-Whitney U test.
*P < 0.05; **P < 0.01; ***P < 0.001
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Fig. 6 Oxidative burst in human PBMCs of bancroftian categories when stimulated with recombinant proteins. Reactive oxygen species (ROS)
generation in PBMCs was measured by flow cytometry using DCF-DA after stimulating with recombinant proteins a Bm-TPP; b BmAF-Myo; c Wol
Tl IF-1; and d wBm-LigA. Unstimulated PBMCs (US) and stimulated PBMCs (St) data are summarized as mean + standard deviation (n= 5). Presentation of
shifting of florescence peak of different proteins in (e) EN group; f MF group; and g CP group. Stimulated groups were compared using Kruskal-Wallis
ANOVA and the significance of the differences in mean ranks between groups was assessed by Mann-Whitney U test. *P< 0.05; **P< 0.01; ***P< 0.001
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in the current investigation. The ADCC-mediated killing
of L3 clearly shows that EN antibodies play an important
role in killing of larval B. malayi since the phenomenon
was highest in this serum category. Amongst all, Bm-
TPP and wBm-LigA revealed best results with EN sera
as far as ADCC is concerned. These results could be
correlated with our previous animal studies. IgG, iso-
types, cellular proliferation and ROS generation also
indicate possible role of these two proteins in the
host at early infection. Individuals of MF group are
hypo-responsive and therefore their responses were
minimal with any recombinant protein including
these two. Wol Tl IF-1 had more or less similar IgG
and cellular response in EN and CP categories, and
might therefore have some role in host pathology.
Wolbachia has been suggested to play some role in
filarial pathology. The removal of anti-Bm-TPP and
anti-wBm-LigA from EN sera by immunoadsorption
led to significant decrease in cell adherence and lar-
val toxicity. On the other hand, depletion of serum
antibodies to BmAF-Myo reduced the ADCC-
mediated killing by half which was not significant
but other results of this study with BmAF-Myo also
point towards the similar role as that of Bm-TPP
and wBm-LigA. These are preliminary findings and
show that Bm-TPP, wBm-LigA and BmAF-Myo re-
combinant proteins possibly become exposed to host
during very early infection stages while Wol Tl IF-1
also play some role in host pathology.
Altogether, our study shows that a putatively immune
population in an endemic area carries antibodies not
only against B. malayi recombinant proteins but also
against its endosymbiont antigens. It is reported that
adult worm death results into Wolbachia release and
most of the Wolbachia proteins participate in inflamma-
tory responses [49]. Wol Tl IF-1 is released as ES prod-
ucts by live adult B. malayi and a recent report indicates
that the vertebrate host becomes exposed to Wolbachia
or their products that are released through the lumen of
the secretory-excretory canals of B. malayi [50]. Reports
do exist for the presence of Wolbachia at all life stages
[51, 52] and therefore Wolbachia release in EN subjects
as a result of repeated larval exposure and their subse-
quent killing is justified.
Conclusions
Overall, this study explores immune characterization of
Bm-TPP, BmAF-Myo, Wol Tl IF-1 and wBm-LigA
recombinant proteins in filarial endemic population.
Our findings, along with previous reports, support that
these B. malayi recombinant proteins might be used as
a potential vaccine candidate against bancroftian filaria-
sis. The presence of anti-Wolbachia antibodies in the
EN population indicates that Wolbachia proteins may
also play important role during the early stages of infec-
tion; however to validate this observation more research
inputs are needed. These findings are noteworthy in
view of non-availability of a drug or vaccine to target
adult filarial parasites.
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